InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
前日終値
$14.21
+$0.13 · +0.92%
時間外
$14.20
−$0.01 · -0.07%
10月9日 19:30 ET
日中の時刻はETです。市場データは遅延する場合があります。
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
日中レンジ
現在 $14.21
52週レンジ
現在 $14.21
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
85
大幅な割安
センチメント
64
強気
リスク
41
やや高いリスク
モメンタム
52
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
日中レンジ
現在 $14.21
52週レンジ
現在 $14.21
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 3.7億 USD | 3.95億 USD | 4.92億 USD | 4.54億 USD | 3.58億 USD |
| 売上原価 | 7952.5万 USD | 7775.2万 USD | 8070.8万 USD | 7348.5万 USD | 5359.2万 USD |
| 粗利益 | 2.91億 USD | 3.17億 USD | 4.11億 USD | 3.81億 USD | 3.04億 USD |
| 研究開発 | 1331.9万 USD | 1313.7万 USD | 1341万 USD | 1242.5万 USD | 953.2万 USD |
| 販売・一般管理 | 1.92億 USD | 1.91億 USD | 2.02億 USD | 1.71億 USD | 1.28億 USD |
| 営業費用 | 2.06億 USD | 2.05億 USD | 2.16億 USD | 1.83億 USD | 1.36億 USD |
| 受取利息 | 2494.3万 USD | 3093.8万 USD | 2160.7万 USD | 361.2万 USD | 52.5万 USD |
| 減価償却費と償却費 | 69.5万 USD | 72.8万 USD | 62.3万 USD | 68万 USD | 51.7万 USD |
| 営業利益 | 8538.7万 USD | 1.13億 USD | 1.96億 USD | 1.98億 USD | 1.67億 USD |
| 純利益 | 9383.1万 USD | 1.81億 USD | 1.98億 USD | 1.62億 USD | 1.65億 USD |
会社概要が更新されました 2026年10月10日.
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$19.00
上昇余地(33.71%)| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2021年10月1日 | 2:1 | — | — |
発効済み 2021年10月1日
2:1
この株式へのエクスポージャーを報告している上場投資信託です。
iShares Core MSCI EAFE ETFIEFA784.23万0.00%1881.24億 USD0.07%$96.52+0.68%
iShares MSCI EAFE Small-Cap ETFSCZ242.02万0.02%127.06億 USD0.40%$83.93+0.82%
iShares Core MSCI Total International Stock ETFIXUS217.56万0.00%582.06億 USD0.07%$94.99+0.90%
ARK Israel Innovative Technology ETFIZRL195.92万1.50%1.37億 USD0.49%$28.36+1.61%
Avantis International Small Cap Value ETFAVDV147.71万0.01%198.57億 USD0.36%$108.52+0.74%
iShares MSCI Israel ETFEIS143.33万0.17%8.57億 USD0.59%$118.28+0.54%
Schwab Fundamental International Small Company Index ETFFNDC141.25万0.05%30.51億 USD0.39%$49.73+0.73%
iShares Core MSCI International Developed Markets ETFIDEV140.38万0.00%326.42億 USD0.04%$89.21+0.73%
iShares Core MSCI EAFE ETFIEFA
iShares MSCI EAFE Small-Cap ETFSCZ
iShares Core MSCI Total International Stock ETFIXUS
ARK Israel Innovative Technology ETFIZRL
Avantis International Small Cap Value ETFAVDV
iShares MSCI Israel ETFEIS
Schwab Fundamental International Small Company Index ETFFNDC
iShares Core MSCI International Developed Markets ETFIDEVAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。